Tarsus Pharmaceuticals Inc. (TARS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tarsus Pharmaceuticals In...

    NASDAQ: TARS · Real-Time Price · USD
    65.17
    6.40 (10.89%)
    At close: Oct 03, 2025, 3:59 PM
    65.27
    0.15%
    After-hours: Oct 03, 2025, 07:32 PM EDT

    Tarsus Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 94.82M 224.95M 71.66M 171.33M
    Short-Term Investments
    		 196.56M 2.5M 145.37M 483K
    Long-Term Investments
    		 3M 631K 371K 663K
    Other Long-Term Assets
    		 6.09M 1.51M 585K 463K
    Receivables
    		 48.06M 17.71M 3.58M 92K
    Inventory
    		 2.62M 3.11M 4.76M n/a
    Other Current Assets
    		 n/a n/a n/a 4.04M
    Total Current Assets
    		 356.7M 256.13M 225.38M 175.95M
    Property-Plant & Equipment
    		 2.87M 3.35M 1.53M 1.83M
    Goodwill & Intangibles
    		 8.33M 3.87M n/a n/a
    Total Long-Term Assets
    		 20.29M 9.36M 2.49M 2.96M
    Total Assets
    		 376.99M 265.49M 227.86M 178.91M
    Account Payables
    		 27.74M 18.15M 5.5M 2.86M
    Deferred Revenue
    		 n/a n/a n/a 697K
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 48.95M 5.14M 3.69M 55K
    Total Current Liabilities
    		 80.61M 36.94M 15.43M 11.48M
    Long-Term Debt
    		 71.84M 29.82M 19.43M n/a
    Other Long-Term Liabilities
    		 n/a 233K 100K 114K
    Total Long-Term Liabilities
    		 71.84M 31.57M 19.53M 699K
    Total Liabilities
    		 152.46M 68.5M 34.96M 12.18M
    Total Debt
    		 72.45M 31.73M 20.16M 1.89M
    Book Value
    		 224.53M 196.99M 192.9M 166.73M
    Book Value Per Share
    		 5.97 6.70 7.84 8.11
    Common Stock
    		 6K 5K 5K 4K
    Retained Earnings
    		 -360.21M -244.66M -108.76M -46.67M
    Comprehensive Income
    		 179K -2K -74K n/a
    Shareholders Equity
    		 224.53M 196.99M 192.9M 166.73M
    Total Investments
    		 199.56M 3.13M 145.74K 483K

    Add to Watchlist